Lobbying

Breast Cancer Prevention Partners's latest lobbying report covers Q2 2026, at $10K. The four quarters Q4 2025–Q3 2026 total $30K. Its first report covers Q3 2022; the issues it reports most are Chemicals/Chemical Industry and Consumer Issues/Safety/Protection.

Breast Cancer Prevention Partners

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$30K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q3 2022
The first quarter a report named it

Lobbying by quarter

Breast Cancer Prevention Partners lobbying by quarter
Breast Cancer Prevention Partners lobbying by quarter
QuarterAmountReports
Q3 2022$10K1
Q4 2022$10K1
Q1 2023$10K1
Q2 2023$10K1
Q3 2023$10K1
Q4 2023$10K1
Q1 2024$10K1
Q2 2024$10K1
Q3 2024$10K1
Q4 2024$10K1
Q1 2025$10K1
Q2 2025$10K1
Q3 2025$10K1
Q4 2025$10K1
Q1 2026$10K1
Q2 2026$10K1
Q3 2026$00

By issue

  • Chemicals$40K · 16 reports
  • Consumer protection and safety$40K · 16 reports
  • Environment and Superfund$40K · 16 reports
  • Health issues$40K · 16 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES16 reports
  • SENATE16 reports

Firms it paid

Firm
The Raben Group$160K16 quarters

Former officials lobbying for it

Former position
DIEGO SANCHEZLegislative Intern, Office of Representative Mike Coffman (CO-06)Q2 2026
ZACHARY SHABENLegislative Aide, Office of Representative Raja KrishnamoorthiQ4 2022

Lobbying reports

Filed by
07/20for Q2The Raben Group$10K
04/20for Q1The Raben Group$10K
01/20for Q4 2025The Raben Group$10K
25/10/17for Q3 2025The Raben Group$10K
25/07/21for Q2 2025The Raben Group$10K
25/04/21for Q1 2025The Raben Group$10K
25/01/17for Q4 2024The Raben Group$10K
24/10/17for Q3 2024The Raben Group$10K
24/07/18for Q2 2024The Raben Group$10K
24/04/18for Q1 2024The Raben Group$10K
24/01/18for Q4 2023The Raben Group$10K
23/11/06for Q1 2023The Raben Group$10K
23/11/06for Q3 2022The Raben Group$10K
23/10/18for Q3 2023The Raben Group$10K
23/07/20for Q2 2023The Raben Group$10K
23/04/18for Q1 2023The Raben Group$10K
23/01/18for Q4 2022The Raben Group$10K